The 2023 EDGE AWARDS Global Innovation Selection of Titanium Media was announced, and the four major

2023 is the first year after the end of the pandemic, the momentum of economic recovery is encouraging, but it will take time to fully get out of the cycle.

With the theme of "New Vision, New Links", from December 1st to 3rd, the 2023 T-Edge Global Innovation Conference and Edge Awards Innovation Selection will be held in Beijing as the vane of innovation frontiers at home and abroad, inviting top innovation and business leaders at home and abroad to gather together to review the industry insights and development in 2023 and look forward to the technological innovation trends and possibilities in the coming year.

Based on China's large health market with a scale of tens of trillions, the industry will usher in the strongest anti-corruption storm in history in 2023, pharmaceutical and medical device companies will enter a new adjustment cycle, innovative drug pipelines will continue to be "swept up" by overseas giants, and the R&D and innovation market will be thriving.

At the 2023 T-Edge Global Innovation Conference, Titanium released the 2023 Edge Awards Global Innovation Selection List, focusing on the big health industry, and the four major lists of the annual medical and health consumer enterprise, the annual medical innovation enterprise, the best consumer health product of the year, and the best family standing medicine of the year were announced successively.

In the past year, those companies that are still at the forefront of the trend should be recorded, those explorers who still insist on innovation should be repeatedly recognized, and those medical and health consumer products that frequently appear in people's daily lives should also be crowned.

The award will be presented to benchmark companies that have always been committed to promoting the return of consumer healthcare to the essence of the health industry, whether they have popular products that are loved by the public, or popular services with high demand under new consumer Xi, they focus on technological innovation and user experience, and their products and services have high-quality growth potential.

The 2023 Edge Awards Global Innovation Awards' Edge Awards Annual Medical and Health Consumer Enterprise list was officially announced, and the winners include:Amway, Dingdang Health, Gushengtang Traditional Chinese Medicine, Bloomage Biotechnology, Meinian Health Group, such as Phoenix, Nu Skin, Yonghe Medical,Left point of the pharmacist gang, zdeer.

Amway].

Amway's corporate vision is to "help people live healthier, better lives". In the context of the macro policy of "Healthy China" construction, Amway China has adjusted its corporate strategy and resource allocation, deeply cultivated the big health track, positioned itself as a "comprehensive health promoter", increased R&D and innovation, consolidated its digital operation capabilities, built a strong and flexible first-chain system, supported marketers to operate a big health community, shaped the public's healthy lifestyle, and achieved a steady rebound in performance while creating social value.

Dingdang Health is an instant health home service company, which has established a large health ecosystem of "medical inspection insurance", and provides users with 7*24 hours of business in the core area, instant delivery of medicines to their homes, as well as free consulting services for professional doctors and pharmacists, chronic disease management and other health services through self-operated entity chain smart pharmacies and the establishment of a professional drug distribution team. Dingdang Health has established online and offline integrated professional medical services, which can provide fast medicine services, first-class health consulting services, chronic diseases and health management services, and has digital technology capabilities, focusing on the research and development and application of artificial intelligence, 5G and Internet of Things and other technologies.

Founded in 2010, Gushengtang TCM is a leading TCM chain management group in China that integrates centralized medical diagnosis and treatment, drug research and development, and TCM talent training. Since its establishment, Gushengtang has taken "good medical treatment, good medicine, and good service" as its core business philosophy to provide high-quality grassroots Chinese medicine diagnosis and treatment services for the general public. At the same time, Gushengtang empowers medical services through digitalization and "Internet +", and successfully builds an "online + offline" OMO service model, which effectively solves the pain points such as the imbalance of physician resources between regions and meets the diverse medical service needs of patients.

Founded in 2000, Bloomage Biotech is a world-renowned biotechnology company and biomaterials company, focusing on the development and industrial application of bioactives that are conducive to life and health, such as functional sugars, proteins, peptides, amino acids, nucleotides, and natural active compounds. As a platform-based enterprise of the whole biotechnology industry chain, the company's business currently covers bioactive raw materials, medical terminal products, and consumer terminal products (functional skin care products and functional foods). The company is not only the world's largest hyaluronic acid R&D, production and sales enterprise, but also ranks first in the world in the industrialization level of hyaluronic acid. At the same time, the use of synthetic biotechnology in ectoin, ergothioneine, chondroitin sulfate, heparin, collagen, NMN and other bioactive substances to gradually achieve industrial transformation.

As a leading medical group specializing in hair medical services in China, Yonghe Medical provides one-stop hair medical services covering hair transplantation, medical maintenance, routine maintenance and other supporting services. The Group has been focusing on the hair medical service market, and has built a brand matrix of the whole industry chain with "Yonghe Medical" as the core, composed of the professional hair transplant brand "Yonghe Hair Transplant", the medical care brand "Shi Yunxun", the female aesthetic hair transplant brand "Yonghe Hair Beginning" and the medical wig brand "Hafafa".

Relying on a nationwide network layout, tens of millions of customer groups, massive professional health big data, and a standardized medical and health service system, Meinian Health provides high-quality health management services for corporate and individual customers in the fields of professional prevention, accurate screening, chronic disease management, and health insurance services, and has a significant influence in the field of preventive medicine.

Founded in 2023 and located in Chengdu, Sichuan Province, Phoenix Renewable Technology Development (Chengdu)** is an enterprise mainly engaged in research and experimental development. For example, Phoenix Regeneration Technology has created youthful anti-aging solutions with the key technology, products and services of "regenerating collagen", and has laid out a non-animal source "Pogment Bogin" regenerated collagen raw material technology platform with independent intellectual property rights, industrial production, and complete triple helix structure, as well as a product development platform for "Smatender Zhiju" terminal medical devices and functional skin care products.

Founded in 1984 in Utah, Nu Skin is a multinational company deeply engaged in the field of personal care and nutritional supplements, listed on the New York ** Stock Exchange in 1996, and has operations in nearly 50 markets in Asia, America, Europe, Africa and the Pacific.

Founded in 2015, Pharmacist Bang is the largest digital integrated service platform in China's out-of-hospital pharmaceutical industry. Pharmacist is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, drug distributors, pharmacies and primary medical institutions, and strives to bring pharmaceutical and health products and services to the downstream in a safe and efficient way, so that users can easily obtain a large number of comprehensive and quality-assured drugs in a fair and transparent manner. With the mission of making good doctors and good medicines accessible to all, Pharmacist Gang drives the improvement of the overall efficiency of the medical and health ecosystem.

ZDEER Left Point focuses on family health. With the theme of "life is light".SlowThrough the three-dimensional perspective of intelligent science, health philosophy and life aesthetics, it proposes solutions to the three major health needs of young people in their daily life: "health preservation", "maintenance" and "recuperation". It has built manufacturing factories in Xuchang, Henan Province and Changsha, Hunan, and set up twin R&D centers in Wuhan and Shenzhen, insisting on long-term value, starting from science and technology and medical treatment, building high R&D barriers, and has applied for more than 100 invention patents, nearly 3,000 independent patents, and has 14 medical device registration certificates of the People's Republic of China.

Titanium**2023 Edge Awards Global Innovation Awards' Edge Awards Medical Innovation Enterprise of the Year list was officially announced, and the winners include:GlaxoSmithKline ChinaUnited Imaging Medical, Easy Group, Easy Health, Ternary Gene, Tongxin Medical, Peach Health, WeDoctor, Xianruida, Yuanxin Technology.

GlaxoSmithKline China

GlaxoSmithKline is a leading vaccine provider in China, committed to improving access to vaccines for Chinese patients and consumers. GlaxoSmithKline's pediatric and ** vaccines protect against a wide range of diseases, including the herpes zoster vaccine, the cervical cancer vaccine, and the hepatitis B virus vaccine in both pediatric and pediatric dosage forms. In recent years, GlaxoSmithKline has accelerated the launch of nearly 20 innovative vaccines and drugs in China, including a number of blockbuster products with breakthrough** products, and continues to expand into new indications.

Shanghai United Imaging Medical Technology Co., Ltd. is committed to providing global customers with a full line of self-developed high-performance medical imaging diagnosis and advanced equipment, life science instruments, and innovative solutions covering the whole chain of "basic research-clinical research-medical translation". Through in-depth collaboration with universities, hospitals, research institutions and industrial partners around the world, we continue to break through the boundaries of scientific and technological innovation, accelerate the promotion of precision diagnosis and treatment and forward-looking scientific research exploration, and continue to improve the accessibility of global high-end medical equipment and services.

Founded in 2014, Easy Group focuses on the field of public health protection. The "Serious Illness Relief" model, pioneered by Easy Group and Easy Chip, introduces strong social relationships into the process of seeking help, and helps many patients solve the problem of medical funds in the first time. At present, Easy Group has formed four major business segments: Easy Fundraising, Easy Strict Selection, Easy Health, and Easy Public Welfare, and has established a public health security system featuring platforms and science and technology as the cornerstone. 2023 marks the 9th anniversary of the establishment of Easy Group, and the group has announced a series of blockbuster cooperation, deeply involved in digital diagnosis and treatment, early cancer screening and other fields.

Founded in 1992, Beijing Sanyuan Gene Pharmaceutical Co., Ltd. is a biopharmaceutical company listed on the Beijing Stock Exchange. Ternary Gene is mainly engaged in the research, development, production and sales of modern biomedical products, and is a leading enterprise in the field of basic research and clinical application development of genetic engineering drugs in China. The company's product human interferon 1b was developed by Academician Hou Yunde, the first chairman of the company and winner of the highest national science and technology award, and is an internationally original genetic engineering drug.

Founded in 2008, Suzhou Tongxin Medical Technology Co., Ltd. is committed to the research and development, production and sales of technologically breakthrough ventricular assist devices (also known as "VAD", "artificial heart"). Ventricular assist device is one of the symbols that reflects the scientific and technological level of a country's high-end medical devices. After more than 10 years of development, with the accumulation of technology in the field of full magnetic levitation VAD, the Cifu implantable left ventricular assist system (hereinafter referred to as "Cifu VAD") independently developed by Tongxin Medical has become the first full magnetic levitation VAD with complete independent intellectual property rights approved for marketing in China. As of August this year, nearly 40 hospitals across the country have used domestic full magnetic levitation artificial hearts, and more than 140 patients with end-stage heart failure have started a "heart" life.

Founded in 2017 and headquartered in Chengdu, Sichuan, Peach Health is a software technology company that provides comprehensive services for the digital healthcare industry, and can provide medical enterprises with the construction and operation services of digital business scenarios. Nearly 100 online diagnosis and treatment platforms built by Taozi Health Service have linked more than 600,000 doctors and 500 million+ patients. Peach Health's full-cycle TOB industry services around the four core sectors of "software development, industrial operation, medical services, and chain integration" have helped more than 5,000 customers complete efficient digital business implementation.

WeDoctor Holdings is a leading international digital health platform, committed to empowering participants in the medical service value chain, such as medical service providers, payers, and ** chains. As an explorer of Internet hospitals, WeDoctor has explored the first municipal-level digital chronic disease management service model in Tai'an, Shandong Province, which can be directly settled by medical insurance, and has been promoted in 16 cities in ShandongLaunched the first domestic digital medical alliance led by digital hospitals in Tianjin, connecting all 266 primary medical institutions in Tianjin, accounting for more than 1110,000 diabetic patients are provided with digital chronic disease management services.

Xianruida is a world-leading innovative medical technology company, focusing on the R&D and application of technology platforms in the field of vascular intervention. Relying on the unique four major technology platforms - drug coating technology, radiofrequency ablation technology, polymer material technology and suction platform technology, Xianruida continues to innovate the best way in the field of vascular intervention through a diversified product portfolio, continues to resist vascular diseases, and continuously brings better systemic vascular interventional solutions to doctors and patients around the world, helping patients achieve long-term clinical benefits and improve their quality of life.

Founded in 2015 and headquartered in Beijing, Beijing Yuanxin Technology Group Co., Ltd. has received multiple rounds of investment of more than one billion yuan from institutions including Tencent, Sequoia Capital, Qiming Capital, Star Capital, etc., and has become a unicorn enterprise in the field of "Internet + medical care" and chronic disease management in China. Through an in-depth understanding of the industry, Yuanxin Technology has established an innovative diagnosis and treatment path, and divided the path into three scenarios: "medical treatment, medication, and payment", and has become a leading comprehensive service platform for medical treatment, medication, and payment in China. In 2023, Yuanxin Technology will officially launch the Source Patient Management Model and the Vibro Model to demonstrate the achievements of the model in the field of post-hospital patient health management.

Titanium** 2023 Edge Awards' Edge Awards Best Consumer Health Products of the Year list was officially announced, and the winning products include:Chang Weiqing, Fuerjia, Lishen, Omron atrial fibrillation blood pressure monitor, Shancun.

Chang Weiqing].

After seven years of research and development, Chang Weiqing, a subsidiary of Nuohui Health, has completed China's first prospective, large-scale, multi-center cancer early screening registration clinical trial, and is currently the only colorectal cancer screening product approved by the State Food and Drug Administration in China. As of November 10, Chang Weiqing's cumulative inspection volume in 2023 has reached 880,000, and the confirmed revenue has exceeded 1 billion yuan.

Based on the research of sodium hyaluronate and collagen, the company has formed a three-dimensional product system suitable for mild to moderate acne, promote wound healing and repair of medical device products, supplemented by various forms of functional skin care products. It has accumulated a good market reputation.

As a well-known nutrition brand, Lishen from Bayer Consumer Health has a long history of 88 years, and has been committed to helping people improve their immunity against diseases since entering China in 2002. In 2022, the Lishen brand ushered in an upgrade, from a single brand to a comprehensive nutrition brand, and at the 2023 Shanghai International Import Expo, Bayer successfully launched Lixen ** triangular calcium and other products, committed to comprehensively enhancing human immunity from multiple dimensions.

This year coincides with the 50th anniversary of the release of Omron sphygmomanometers, since the birth of the first sphygmomanometer in 1973, Omron sphygmomanometer products have been distributed in more than 130 countries and regions around the world, with a cumulative global sales of more than 3500 million units. Over the past 50 years, Omron has continued to promote the evolution of blood pressure management, insisted on continuous innovation and breakthroughs to achieve the goal of "zero episodes of cardiovascular and cerebrovascular events", and focused on the research of early perception of disease signs, committed to building a preventive medical mechanism, and helped chronic disease management move from prevention to a new stage of prevention.

As one of the world's leading independent consumer health companies, Haleon owns a series of consumer health product brands that are deeply loved and respected by consumers and experts, such as Calcium, Shancun, Comforta, Fenbid, Voltarin, Xincontec, Baiduobang, Fushuliang, and Polyden, among which Shancun is an international compound vitamin mineral brand that has been focusing on multivitamin and mineral research for more than 40 years.

The 2023 Edge Awards Global Innovation Awards' Edge Awards Best Home Standing Medicine of the Year list was officially announced, and the winning products include:Banlangen Granules, Smecta, Tylenol, Tongren Wuji Baifeng Pills, Pediatric Pulmonary Fever Cough and Asthma Oral Liquid.

【Radix granules】

Guangzhou Baiyunshan Hutchison Whampoa Traditional Chinese Medicine*** was established in May 2005 as a joint venture between Guangzhou Pharmaceutical Group Baiyunshan Pharmaceutical Co., Ltd. and Hutchison Whampoa (China) Co., Ltd. At present, Baiyunshan Hutchison Chinese Medicine has become the largest monomer Chinese patent medicine manufacturing enterprise in South China and the largest production base of Banlangen in China. In November 2022, Guangzhou Pharmaceutical Group (GPC) Baiyunshan Compound Banlangen Granules (Low Sugar) was successfully approved for the registration certificate of proprietary Chinese medicine in Macao.

Smecta is a world-renowned brand in the field of intestinal health, founded in France in 1975, and its Smecta montmorillonite powder specializes in acute and chronic diarrhea and acute diarrhea in children. Smecta entered the Chinese market in 1992, and after 30 years of deep cultivation in the field of children and digestive diseases, it has become a trusted brand for doctors, patients and consumers. In order to meet the needs of users for convenient medication in travel scenarios, a new dosage form of montmorillonite suspension was officially launched this year.

Founded in 1971 under the umbrella of Johnson & Johnson, Tylenol has been the best-selling brand in the global cold and pain medicine category. In 1995, Tylenol entered China, and in the same year, Johnson & Johnson of the United States established a pharmaceutical company specializing in the production of self-care drugs in Shanghai, and its products were recognized by professional medical staff and pharmacists, and Tylenol was one of the representatives.

Beijing Tong Ren Tang Co., Ltd. is the first listed company under Tong Ren Tang Group. The company produces more than 400 specifications of Chinese patent medicines all year round, forming a cardiovascular and cerebrovascular series represented by Angong Niuhuang Pill, Tongren Niuhuang Qingxin Pill and Tongren Dahuo Luo Pill, and ** series represented by Tongren Wuji Baifeng Pill and Kunbao Pill, among them, Tongren Wuji Baifeng Pill originated from the "Baifeng Dan" in the "Shoushi Baoyuan" written by Gong Tingxian, a famous doctor in the Ming Dynasty, and was the imperial medicine of the palace in the Qing Dynasty.

Pediatric Pulmonary Fever Cough and Asthma Oral Liquid is one of the varieties of sunflower medicine, and it and Pediatric Chai Gui Antipyretic Granules have both entered the "Clinical Application Guide of Pediatric Acute Upper Respiratory Tract Infection of Pediatric Proprietary Chinese Medicine" prepared by experts led by the State Administration of Traditional Chinese Medicine. In March this year, the "Guidelines for Clinical Diagnosis and Treatment of Pediatric Viral Pneumonia in Traditional Chinese Medicine (Revised)" was released, among which, in the part of Chinese patent medicine, the recommended level of pediatric pulmonary fever cough and asthma oral liquid is the only A-level.